Cargando…

Oculogyric crisis symptoms related to risperidone treatment: a case report

BACKGROUND: Oculogyric crisis (OGC) is a rare focal dystonia of the ocular muscles that not only interferes with patients’ medication adherence but also negatively affects the course and prognosis of the primary disease. Early detection and treatment of OGC can improve patients’ medication adherence...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Tao, Wu, Liping, Li, Longlong, Zhang, Min, Tan, Qingyu, Liu, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675969/
https://www.ncbi.nlm.nih.gov/pubmed/38001400
http://dx.doi.org/10.1186/s12888-023-05379-3
_version_ 1785149887905529856
author Lv, Tao
Wu, Liping
Li, Longlong
Zhang, Min
Tan, Qingyu
Liu, Ping
author_facet Lv, Tao
Wu, Liping
Li, Longlong
Zhang, Min
Tan, Qingyu
Liu, Ping
author_sort Lv, Tao
collection PubMed
description BACKGROUND: Oculogyric crisis (OGC) is a rare focal dystonia of the ocular muscles that not only interferes with patients’ medication adherence but also negatively affects the course and prognosis of the primary disease. Early detection and treatment of OGC can improve patients’ medication adherence and quality of life. CASE PRESENTATION: This paper reports a case of a 19-year-old Asian female with a diagnosis of schizophrenia who was treated intermittently with atypical antipsychotics aripiprazole or risperidone for 2 years, with improvement of psychotic symptoms during the course of medication, and then developed double eye rolling and staring with irritability when treated with risperidone 4 mg/d or 6 mg/d. Then, we changed the medication to clozapine, and the patient’s psychotic symptoms were controlled and stable. The symptoms of double eye rolling and gaze disappeared. CONCLUSION: Oculogyric crisis (OGC) is a rare focal dystonia of the oculogyric muscle. This case provides clinicians with a basis for the early recognition and management of oculogyric crisis during the use of atypical antipsychotics (risperidone).
format Online
Article
Text
id pubmed-10675969
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106759692023-11-24 Oculogyric crisis symptoms related to risperidone treatment: a case report Lv, Tao Wu, Liping Li, Longlong Zhang, Min Tan, Qingyu Liu, Ping BMC Psychiatry Case Report BACKGROUND: Oculogyric crisis (OGC) is a rare focal dystonia of the ocular muscles that not only interferes with patients’ medication adherence but also negatively affects the course and prognosis of the primary disease. Early detection and treatment of OGC can improve patients’ medication adherence and quality of life. CASE PRESENTATION: This paper reports a case of a 19-year-old Asian female with a diagnosis of schizophrenia who was treated intermittently with atypical antipsychotics aripiprazole or risperidone for 2 years, with improvement of psychotic symptoms during the course of medication, and then developed double eye rolling and staring with irritability when treated with risperidone 4 mg/d or 6 mg/d. Then, we changed the medication to clozapine, and the patient’s psychotic symptoms were controlled and stable. The symptoms of double eye rolling and gaze disappeared. CONCLUSION: Oculogyric crisis (OGC) is a rare focal dystonia of the oculogyric muscle. This case provides clinicians with a basis for the early recognition and management of oculogyric crisis during the use of atypical antipsychotics (risperidone). BioMed Central 2023-11-24 /pmc/articles/PMC10675969/ /pubmed/38001400 http://dx.doi.org/10.1186/s12888-023-05379-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Lv, Tao
Wu, Liping
Li, Longlong
Zhang, Min
Tan, Qingyu
Liu, Ping
Oculogyric crisis symptoms related to risperidone treatment: a case report
title Oculogyric crisis symptoms related to risperidone treatment: a case report
title_full Oculogyric crisis symptoms related to risperidone treatment: a case report
title_fullStr Oculogyric crisis symptoms related to risperidone treatment: a case report
title_full_unstemmed Oculogyric crisis symptoms related to risperidone treatment: a case report
title_short Oculogyric crisis symptoms related to risperidone treatment: a case report
title_sort oculogyric crisis symptoms related to risperidone treatment: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675969/
https://www.ncbi.nlm.nih.gov/pubmed/38001400
http://dx.doi.org/10.1186/s12888-023-05379-3
work_keys_str_mv AT lvtao oculogyriccrisissymptomsrelatedtorisperidonetreatmentacasereport
AT wuliping oculogyriccrisissymptomsrelatedtorisperidonetreatmentacasereport
AT lilonglong oculogyriccrisissymptomsrelatedtorisperidonetreatmentacasereport
AT zhangmin oculogyriccrisissymptomsrelatedtorisperidonetreatmentacasereport
AT tanqingyu oculogyriccrisissymptomsrelatedtorisperidonetreatmentacasereport
AT liuping oculogyriccrisissymptomsrelatedtorisperidonetreatmentacasereport